Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 26, 2026
TickeronGET DAILY SIGNALS
Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Key Takeaways

  • Rocket Lab shares closed at $63.91 on July 24, 2026, meaning the stock would need to climb approximately 56% to reclaim the psychologically significant $100 level.
  • The strongest bullish catalyst is Neutron, the company's medium-lift reusable rocket targeting a debut launch in the fourth quarter of 2026, which could unlock a $5.6 billion national security launch program and dramatically expand the revenue base.
  • Rocket Lab's record $2.2 billion backlog and 63.5% year-over-year revenue growth in Q1 2026 demonstrate strong operational momentum, while the pending $8 billion Iridium acquisition could transform the company into a vertically integrated space platform with recurring services revenue.
  • Valuation and dilution risks remain significant obstacles. The stock trades at roughly 66 times trailing sales, insider selling has weighed on sentiment, and a $3 billion at-the-market equity offering has raised concerns about shareholder dilution.
  • Wall Street consensus suggests $100 is achievable. The average analyst price target stands near $110, with most targets clustering between $96 and $135, though the Street-low target of $60 underscores the wide range of possible outcomes.

Why Investors Are Watching the $100 Level

After peaking near $151 in May 2026, Rocket Lab Corporation (NASDAQ: RKLB) has endured a punishing drawdown of more than 55%, wiping out the year's gains and sending shares tumbling into the mid-$60s. The speed and severity of the sell-off — driven by a broader post-SpaceX IPO rotation out of space stocks, a dilutive equity offering, and a securities class action — has left investors asking whether the stock can mount a meaningful recovery. The $100 round-number level has emerged as the most visible near-term milestone: it sits just below the analyst consensus, represents the threshold that separated the stock's rally phase from its correction, and carries the psychological weight that round numbers command in technical analysis.

Company Overview

Rocket Lab is an end-to-end space company headquartered in Long Beach, California, founded in 2006 by CEO Sir Peter Beck. Unlike pure-play launch providers, Rocket Lab operates across two segments: Launch Services, anchored by the frequently flown Electron small orbital rocket, and Space Systems, which designs and manufactures satellites, spacecraft components, and on-orbit infrastructure. The company has delivered more than 1,700 satellites to orbit, operates three launch pads across New Zealand and Virginia, and is developing Neutron, a medium-lift reusable rocket designed to compete directly with SpaceX's Falcon 9 in the constellation-deployment and national security markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Drive the Stock Back to $100

The single most important variable for the Rocket Lab thesis is Neutron's debut flight, now targeted for the fourth quarter of 2026. A successful first launch would make Rocket Lab eligible to compete for individual task orders under the Space Force's National Security Space Launch (NSSL) Phase 3 Lane 1 program, a contract vehicle carrying a $5.6 billion ceiling through 2029. The Archimedes engine that powers Neutron recently completed a full-duration qualification burn at NASA's Stennis Space Center — a milestone that keeps the timeline credible despite an earlier tank-test failure that pushed the schedule from mid-2026 into the fourth quarter.

Beyond Neutron, the fundamental momentum is difficult to dismiss. First-quarter fiscal 2026 revenue reached $200.35 million, up 63.5% year over year, while the contracted backlog swelled to a record $2.2 billion. Rocket Lab also secured an $816 million Space Development Agency contract for 18 tracking-layer satellites and was selected alongside Raytheon for the Golden Dome Space-Based Interceptor program — placing the company at the center of the highest-priority U.S. defense space budgets.

The pending $8 billion acquisition of Iridium Communications, announced in late June 2026, represents a transformative bet. If the deal closes as expected in mid-2027, Rocket Lab would add a global satellite communications network, L-band spectrum, and more than 2.5 million recurring subscribers — evolving from a launch provider into a vertically integrated space platform that more closely resembles the SpaceX model Morgan Stanley has cited in its analysis.

Analyst Consensus: Cautious Optimism

The broader analyst community remains constructive despite the sell-off. Across 22 analysts, the consensus rating is Moderate Buy, with an average price target of approximately $110, implying roughly 72% upside from the most recent close. High-profile targets include Needham at $120, Keybanc at $135, and Bank of America at $115. Morgan Stanley maintains an Overweight rating with a $105 base case while simultaneously raising its bull-case scenario to $293, reflecting the optionality tied to Neutron, Iridium, and Golden Dome contract conversions. On the more cautious side, Piper Sandler initiated coverage in mid-July with a Neutral rating and an $83 target, arguing the stock remains expensive even after falling more than 50% from its peak. The range of opinion — from $60 at Wells Fargo to $150 at the high end — underscores how much depends on execution over the next two quarters.

Risks That Could Prevent the Move

Rocket Lab remains an unprofitable company. Fiscal 2025 revenue of $601.8 million was accompanied by a net loss of $198 million, and the company trades at roughly 66 times trailing sales — a multiple that prices in years of flawless execution. Any Neutron delay beyond late 2026, whether from technical setbacks or certification hurdles, would delay the medium-lift revenue stream that the valuation thesis depends on and could trigger further equity dilution.

Additional headwinds include a $3 billion at-the-market equity offering announced in June, which raised dilution concerns, and insider selling from CEO Peter Beck, who disclosed the sale of nearly 3 million shares in early July. A securities class action filed over Neutron timeline disclosures has added legal uncertainty to the mix. Meanwhile, the post-SpaceX IPO rotation has not yet run its course, and with a beta of approximately 2.55, RKLB amplifies every shift in market sentiment — in both directions.

Technical Levels That Matter

From a technical perspective, $100 also aligns as the approximate midpoint between the 52-week high of $151 and key support near $60 — the Street-low analyst target and a level the stock tested during the recent sell-off. The 200-day simple moving average, sitting around $76, represents a nearer-term hurdle; the stock would need to reclaim that level before any sustained move toward triple digits gains credibility. The $80 to $85 zone, where the stock consolidated during portions of June and early July, may also act as an intermediate resistance area. I reviewed the recent patterns using Tickeron’s AI Pattern Search Engine to confirm the key levels.

Using AI Tools to Navigate Volatile Names

One tool I’ve found helpful for navigating stocks like this is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. Rather than manually scanning charts and news feeds, I can use these signals to identify emerging opportunities, monitor existing positions, and spot shifts in market trends more efficiently. For investors tracking whether RKLB can sustain a recovery toward $100, automated signal monitoring can help filter the noise from the signal.

Final Assessment

Can Rocket Lab reach $100? The arithmetic says yes — a 56% rally from $63.91 is well within this stock's normal range of motion, and it has already traded well above $100 earlier in 2026. The question is less about capability and more about timing and conditions. A clean Neutron debut in the fourth quarter, continued backlog conversion at or above current growth rates, and tangible progress on the Iridium integration would likely provide the fundamental fuel to drive shares back through $100. Conversely, a Neutron delay into 2027, further dilution, or deteriorating sentiment across the space sector would make that target considerably more difficult. For now, $100 remains a reachable but non-trivial milestone — one that demands execution, not merely ambition. The upcoming Q2 earnings report on August 6 may offer the next meaningful signal about which direction the stock is poised to take.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RKLB's RSI Indicator entering oversold zone

The RSI Indicator for RKLB moved into overbought territory on November 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 198 of 239 cases where RKLB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In 64 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

The Moving Average Convergence Divergence Histogram (MACD) for RKLB turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.421) is normal, around the industry mean (4.689). RKLB's P/E Ratio (-170.333) is considerably lower than the industry average of (17.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 35.06B. The market cap for tickers in the group ranges from 4.49 to 1.63T. SPCX holds the highest valuation in this group at 1.63T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -9%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -24%. BETA experienced the highest price growth at 17%, while VWAV experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was 37% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 54
Price Growth Rating: 66
SMR Rating: 78
Profit Risk Rating: 79
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
ExxonMobil reported GAAP net earnings of $4.2 billion, or $1.00 per diluted share (EPS), down from $7.7 billion, or $1.76 per share, in Q1 2025. Adjusted earnings excluding identified items reached $4.9 billion, or $1.16 per share, surpassing consensus estimates around $1.00 to $1.07.